Lymphocyte cytotoxicity to influenza virus-infected cells: response to vaccination and virus infection
- PMID: 669816
- PMCID: PMC421906
- DOI: 10.1128/iai.20.3.640-645.1978
Lymphocyte cytotoxicity to influenza virus-infected cells: response to vaccination and virus infection
Abstract
Peripheral blood leukocytes obtained from volunteers at various times following influenza vaccine or live influenza virus infection were assayed for cytotoxicity against influenza virus-infected cells. Cytotoxicity was highest on days 3 and 7 following vaccination with commercial A/Port Chalmers/1/73 inactivated influenza virus vaccine. Maximal cytotoxicity was found 9 days after infection induced by intranasal inoculation of a strain of A/Scotland/840/74 influenza virus. Individuals naturally infected with A/Victoria/3/75 were also found to have elevated cytotoxicity approximately 1 week after onset of illness. Cytotoxicity levels decreased toward base line approximately 30 days after the virus exposure. The effector mechanism(s) responsible for the early, transient elevation in specific immune release to influenza virus-infected cells may be different from the antibody-dependent cell cytotoxicity demonstrated in the peripheral blood leukocytes from volunteers who had a remote experience with influenza virus.
Similar articles
-
Cell-mediated cytotoxicity following influenza infection and vaccination in humans.J Med Virol. 1979;4(1):1-14. doi: 10.1002/jmv.1890040102. J Med Virol. 1979. PMID: 231094
-
Lymphocyte cytotoxicity to influenza virus-infected cells. II. Requirement for antibody and non-T lymphocytes.J Immunol. 1977 Dec;119(6):2100-6. J Immunol. 1977. PMID: 334984
-
Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation.Proc Natl Acad Sci U S A. 1979 Sep;76(9):4622-6. doi: 10.1073/pnas.76.9.4622. Proc Natl Acad Sci U S A. 1979. PMID: 291990 Free PMC article.
-
Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine.J Immunol. 2014 Jul 15;193(2):469-75. doi: 10.4049/jimmunol.1400432. J Immunol. 2014. PMID: 24994909 Review.
-
Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?Jpn J Infect Dis. 2016;69(3):165-79. doi: 10.7883/yoken.JJID.2015.560. Jpn J Infect Dis. 2016. PMID: 27212584 Review.
Cited by
-
What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.EBioMedicine. 2016 Jun;8:277-290. doi: 10.1016/j.ebiom.2016.04.029. Epub 2016 Apr 28. EBioMedicine. 2016. PMID: 27428437 Free PMC article.
-
Interactions between immune cells and antibody in protection from fatal Sindbis virus encephalitis.Infect Immun. 1979 Feb;23(2):320-4. doi: 10.1128/iai.23.2.320-324.1979. Infect Immun. 1979. PMID: 311344 Free PMC article.
-
Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines.Vaccines (Basel). 2021 Jan 20;9(2):71. doi: 10.3390/vaccines9020071. Vaccines (Basel). 2021. PMID: 33498370 Free PMC article.
-
Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza.J Immunol. 2018 Mar 15;200(6):2057-2066. doi: 10.4049/jimmunol.1701088. Epub 2018 Feb 2. J Immunol. 2018. PMID: 29427414 Free PMC article.
-
Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine.Infect Immun. 1980 Nov;30(2):362-9. doi: 10.1128/iai.30.2.362-369.1980. Infect Immun. 1980. PMID: 7439982 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical